Exact Mass: 419.213
Exact Mass Matches: 419.213
Found 500 metabolites which its exact mass value is equals to given mass value 419.213
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Roquefortine F
Roquefortine F is a fungal secondary metabolite classified as an indole diterpene. It is produced by certain species of Penicillium fungi, notably those used in the production of Roquefort cheese. This compound belongs to a family of organic compounds characterized by the presence of an indole ring and a diterpene backbone. Indole diterpenes are known for their diverse biological activities, which can include antibiotic, antitumor, and anti-inflammatory effects. Roquefortine F, in particular, has been of interest in the fields of food science and pharmaceutical research. In the context of food, it can contribute to the flavor profile and safety of certain fermented products. In drug development, it may serve as a template molecule for the synthesis of new pharmaceuticals due to its unique chemical structure and potential therapeutic properties. The exact chemical structure of Roquefortine F can be complex, featuring a bicyclic core with various functional groups attached to the indole ring and diterpene scaffold. This complexity contributes to its diverse biological activities and potential applications in different fields.
11-Deoxycortisol-3-carboxymethyloxime
(3E)-1-[1-(4-Fluorophenyl)ethyl]-3-[[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]methylidene]piperidin-2-one
Adimolol
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist
Caldiamide
(4-((5,6-Diphenylpyrazin-2-yl)(isopropyl)amino)butoxy)acetic acid
7-(4,5-Dimethoxy-2-methyl-1-naphthalenyl)-3,4-dihydro-6,8-dimethoxy-1,3-dimethylisoquinoline
1,3-Dimethyl-6,8-dimethoxy-5-(4,5-dimethoxy-7-methyl-1-naphthyl)-3,4-dihydroisoquinoline
Ser Asp Ala Lys
Ser Ala Asp Lys
MRE-269
MRE-269 is an active metabolite of selexipag, and acts as a selective IP receptor agonist.
MLS002153420-01!Pregnenolone sulfate sodium salt1852-38-6
C22H29NO7_2H-Isoindole-2-acetic acid, 7-carboxy-1,3-dihydro-6-methoxy-5-methyl-4-[(3-methyl-2-buten-1-yl)oxy]-alpha-(1-methylpropyl)-1-oxo
Ala Ala Cys Arg
Ala Ala Lys Met
Ala Ala Met Lys
Ala Ala Arg Cys
Ala Cys Ala Arg
Ala Cys Lys Val
Ala Cys Arg Ala
Ala Cys Val Lys
Ala Asp Lys Ser
Ala Asp Ser Lys
Ala Lys Ala Met
Ala Lys Cys Val
Ala Lys Asp Ser
Ala Lys Met Ala
Ala Lys Ser Asp
Ala Lys Thr Thr
Ala Lys Val Cys
Ala Met Ala Lys
Ala Met Lys Ala
Ala Gln Thr Thr
Ala Arg Ala Cys
Ala Arg Cys Ala
Ala Arg Ser Ser
Ala Ser Asp Lys
Ala Ser Lys Asp
Ala Ser Arg Ser
Ala Ser Ser Arg
Ala Thr Lys Thr
Ala Thr Gln Thr
Ala Thr Thr Lys
Ala Thr Thr Gln
Ala Val Cys Lys
Ala Val Lys Cys
Cys Ala Ala Arg
Cys Ala Lys Val
Cys Ala Arg Ala
Cys Ala Val Lys
Cys Gly Ile Lys
Cys Gly Lys Ile
Cys Gly Lys Leu
Cys Gly Leu Lys
Cys Ile Gly Lys
Cys Ile Lys Gly
Cys Lys Ala Val
Cys Lys Gly Ile
Cys Lys Gly Leu
Cys Lys Ile Gly
Cys Lys Leu Gly
Cys Lys Val Ala
Cys Leu Gly Lys
Cys Leu Lys Gly
Cys Arg Ala Ala
Cys Val Ala Lys
Cys Val Lys Ala
Asp Ala Lys Ser
Asp Ala Ser Lys
Asp Gly Lys Thr
Asp Gly Thr Lys
Asp Lys Ala Ser
Asp Lys Gly Thr
Asp Lys Ser Ala
Asp Lys Thr Gly
Asp Ser Ala Lys
Asp Ser Lys Ala
Asp Thr Gly Lys
Asp Thr Lys Gly
Glu Gly Lys Ser
Glu Gly Ser Lys
Glu Lys Gly Ser
Glu Lys Ser Gly
Glu Ser Gly Lys
Glu Ser Lys Gly
Gly Cys Ile Lys
Gly Cys Lys Ile
Gly Cys Lys Leu
Gly Cys Leu Lys
Gly Asp Lys Thr
Gly Asp Thr Lys
Gly Glu Lys Ser
Gly Glu Ser Lys
Gly Gly Met Arg
Gly Gly Arg Met
Gly Ile Cys Lys
Gly Ile Lys Cys
Gly Lys Cys Ile
Gly Lys Cys Leu
Gly Lys Asp Thr
Gly Lys Glu Ser
Gly Lys Ile Cys
Gly Lys Leu Cys
Gly Lys Ser Glu
Gly Lys Thr Asp
Gly Leu Cys Lys
Gly Leu Lys Cys
Gly Met Gly Arg
Gly Met Arg Gly
Gly Arg Gly Met
Gly Arg Met Gly
Gly Arg Ser Thr
Gly Arg Thr Ser
Gly Ser Glu Lys
Gly Ser Lys Glu
Gly Ser Arg Thr
Gly Ser Thr Arg
Gly Thr Asp Lys
Gly Thr Lys Asp
Gly Thr Arg Ser
Gly Thr Ser Arg
Ile Cys Gly Lys
Ile Cys Lys Gly
Ile Gly Cys Lys
Ile Gly Lys Cys
Ile Lys Cys Gly
Ile Lys Gly Cys
Ile Asn Ser Ser
Ile Ser Asn Ser
Ile Ser Ser Asn
Lys Ala Ala Met
Lys Ala Cys Val
Lys Ala Asp Ser
Lys Ala Met Ala
Lys Ala Ser Asp
Lys Ala Thr Thr
Lys Ala Val Cys
Lys Cys Ala Val
Lys Cys Gly Ile
Lys Cys Gly Leu
Lys Cys Ile Gly
Lys Cys Leu Gly
Lys Cys Val Ala
Lys Asp Ala Ser
Lys Asp Gly Thr
Lys Asp Ser Ala
Lys Asp Thr Gly
Lys Glu Gly Ser
Lys Glu Ser Gly
Lys Gly Cys Ile
Lys Gly Cys Leu
Lys Gly Asp Thr
Lys Gly Glu Ser
Lys Gly Ile Cys
Lys Gly Leu Cys
Lys Gly Ser Glu
Lys Gly Thr Asp
Lys Ile Cys Gly
Lys Ile Gly Cys
Lys Leu Cys Gly
Lys Leu Gly Cys
Lys Met Ala Ala
Lys Ser Ala Asp
Lys Ser Asp Ala
Lys Ser Glu Gly
Lys Ser Gly Glu
Lys Ser Ser Val
Lys Ser Val Ser
Lys Thr Ala Thr
Lys Thr Asp Gly
Lys Thr Gly Asp
Lys Thr Thr Ala
Lys Val Ala Cys
Lys Val Cys Ala
Lys Val Ser Ser
Leu Cys Gly Lys
Leu Cys Lys Gly
Leu Gly Cys Lys
Leu Gly Lys Cys
Leu Lys Cys Gly
Leu Lys Gly Cys
Leu Asn Ser Ser
Leu Ser Asn Ser
Leu Ser Ser Asn
Met Ala Ala Lys
Met Ala Lys Ala
Met Gly Gly Arg
Met Gly Arg Gly
Met Lys Ala Ala
Met Arg Gly Gly
Asn Ile Ser Ser
Asn Leu Ser Ser
Asn Ser Ile Ser
Asn Ser Leu Ser
Asn Ser Ser Ile
Asn Ser Ser Leu
Asn Ser Thr Val
Asn Ser Val Thr
Asn Thr Ser Val
Asn Thr Val Ser
Asn Val Ser Thr
Asn Val Thr Ser
Gln Ala Thr Thr
Gln Ser Ser Val
Gln Ser Val Ser
Gln Thr Ala Thr
Gln Thr Thr Ala
Gln Val Ser Ser
Arg Ala Ala Cys
Arg Ala Cys Ala
Arg Ala Ser Ser
Arg Cys Ala Ala
Arg Gly Gly Met
Arg Gly Met Gly
Arg Gly Ser Thr
Arg Gly Thr Ser
Arg Met Gly Gly
Arg Ser Ala Ser
Arg Ser Gly Thr
Arg Ser Ser Ala
Arg Ser Thr Gly
Arg Thr Gly Ser
Arg Thr Ser Gly
Ser Ala Lys Asp
Ser Ala Arg Ser
Ser Ala Ser Arg
Ser Asp Lys Ala
Ser Glu Gly Lys
Ser Glu Lys Gly
Ser Gly Glu Lys
Ser Gly Lys Glu
Ser Gly Arg Thr
Ser Gly Thr Arg
Ser Ile Asn Ser
Ser Ile Ser Asn
Ser Lys Ala Asp
Ser Lys Asp Ala
Ser Lys Glu Gly
Ser Lys Gly Glu
Ser Lys Ser Val
Ser Lys Val Ser
Ser Leu Asn Ser
Ser Leu Ser Asn
Ser Asn Ile Ser
Ser Asn Leu Ser
Ser Asn Ser Ile
Ser Asn Ser Leu
Ser Asn Thr Val
Ser Asn Val Thr
Ser Gln Ser Val
Ser Gln Val Ser
Ser Arg Ala Ser
Ser Arg Gly Thr
Ser Arg Ser Ala
Ser Arg Thr Gly
Ser Ser Ala Arg
Ser Ser Ile Asn
Ser Ser Lys Val
Ser Ser Leu Asn
Ser Ser Asn Ile
Ser Ser Asn Leu
Ser Ser Gln Val
Ser Ser Arg Ala
Ser Ser Val Lys
Ser Ser Val Gln
Ser Thr Gly Arg
Ser Thr Asn Val
Ser Thr Arg Gly
Ser Thr Val Asn
Ser Val Lys Ser
Ser Val Asn Thr
Ser Val Gln Ser
Ser Val Ser Lys
Ser Val Ser Gln
Ser Val Thr Asn
Thr Ala Lys Thr
Thr Ala Gln Thr
Thr Ala Thr Lys
Thr Ala Thr Gln
Thr Asp Gly Lys
Thr Asp Lys Gly
Thr Gly Asp Lys
Thr Gly Lys Asp
Thr Gly Arg Ser
Thr Gly Ser Arg
Thr Lys Ala Thr
Thr Lys Asp Gly
Thr Lys Gly Asp
Thr Lys Thr Ala
Thr Asn Ser Val
Thr Asn Val Ser
Thr Gln Ala Thr
Thr Gln Thr Ala
Thr Arg Gly Ser
Thr Arg Ser Gly
Thr Ser Gly Arg
Thr Ser Asn Val
Thr Ser Arg Gly
Thr Ser Val Asn
Thr Thr Ala Lys
Thr Thr Ala Gln
Thr Thr Lys Ala
Thr Thr Gln Ala
Thr Val Asn Ser
Thr Val Ser Asn
Val Ala Cys Lys
Val Ala Lys Cys
Val Cys Ala Lys
Val Cys Lys Ala
Val Lys Ala Cys
Val Lys Cys Ala
Val Lys Ser Ser
Val Asn Ser Thr
Val Asn Thr Ser
Val Gln Ser Ser
Val Ser Lys Ser
Val Ser Asn Thr
Val Ser Gln Ser
Val Ser Ser Lys
Val Ser Ser Gln
Val Ser Thr Asn
Val Thr Asn Ser
Val Thr Ser Asn
L-902,688
3-methyl-5-phenylmethoxy-2-(4-phenylmethoxyphenyl)-1H-indole
dicyclohexyl-[2-(2-methoxyphenyl)indol-1-yl]phosphane
2-Methyl-4-(N-ethyl-N-benzyl)aminobenzoaldehyde-1,1-diphenylhydrazone
(2S,4S)-4-AMINO-1,2-PYRROLIDINEDICARBOXYLICACID1-(1,1-DIMETHYLETHYL)2-METHYLESTER
E 2012
D004791 - Enzyme Inhibitors > D000091062 - Gamma Secretase Inhibitors and Modulators
(R)-(1-methyl-2-tritylisoindolin-5-yl)boronic acid
3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-9-(2-naphthalenyl)carbazole
BUTYLACRYLATE-STYRENE-METHYLOLACRYLAMIDE-METHACRYLICACID
PF-477736
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
{(3s)-1-[5-(Cyclohexylcarbamoyl)-6-(Propylsulfanyl)pyridin-2-Yl]piperidin-3-Yl}acetic Acid
C471 - Enzyme Inhibitor
(6R)-6-[[3,6-Dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy]heptanoic acid
7-[[3,6-Dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy]heptanoic acid
Acetamide, N-[2-[(2-aminoethyl)methylamino]-5-[[3-cyano-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-5-yl]amino]phenyl]-
3-[2-[4-(2-Methoxyphenyl)piperazin-1-yl]ethyl]-1,5-dihydropyrimido[5,4-b]indole-2,4-dione
(2,2-Diphosphonoethyl)(Dodecyl)dimethylphosphonium
(3Z)-3-[(2E,4E,6R)-1-hydroxy-6-[(2S,5R,7R,8R)-5-hydroxy-1,2,7-trimethyl-3,9,10-trioxatricyclo[4.3.1.02,4]decan-8-yl]-4-methylhepta-2,4-dienylidene]pyrrolidine-2,4-dione
3-[5-[(Z)-[(5Z)-4-ethenyl-5-[(4-ethenyl-3-methyl-5-oxopyrrol-2-yl)methylidene]-3-methylpyrrol-2-ylidene]methyl]-2-hydroxy-4-methyl-1H-pyrrol-3-yl]propanoic acid
(3E)-1-[1-(4-Fluorophenyl)ethyl]-3-[[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]methylidene]piperidin-2-one
2-[(Z)-[17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-ylidene]amino]oxyacetic acid
ancistrotanzanine B
An isoquinoline alkaloid that is (3S)-6,8-dimethoxy-1,3-dimethyl-3,4-dihydroisoquinoline substituted by a 4,5-dimethoxy-7-methylnaphthalen-1-yl group at position 5. It is isolated from the leaves of Ancistrocladus tanzaniensis and exhibits antiplasmodial, antileishmanial and antitrypanocidal activities.
2-[[2-(3,4-Dimethoxyphenyl)-5-methyl-4-oxazolyl]methylthio]-1-(4-ethyl-1-piperazinyl)ethanone
N-[4-[4-[2-furanyl(oxo)methyl]-1-piperazinyl]phenyl]-2-(3-methylphenoxy)acetamide
3-[1-[[1-(4-Methoxyphenyl)cyclopropyl]-oxomethyl]-4-piperidinyl]-5-phenyl-1,3,4-oxadiazol-2-one
N-[2-(4-morpholinyl)ethyl]-2-(4-propan-2-yloxyphenyl)-4-quinolinecarboxamide
N-cycloheptyl-2-[[2-(1,3-dioxo-2-isoindolyl)-1-oxoethyl]amino]benzamide
Butyl 3-amino-12,12-dimethyl-8-morpholin-4-yl-11-oxa-5-thia-7-azatricyclo[7.4.0.02,6]trideca-1(9),2(6),3,7-tetraene-4-carboxylate
3-(3,3-Dimethylcyclobutyl)-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-8-amine
N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-(cyclohexylmethyl)-2-[(2S,3R,6R)-3-[[(3-fluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
[1-[3-(4-Fluorophenoxy)propyl]-4-piperidinyl]-diphenylmethanol
(2S,3S,4R)-2-cyano-N-cyclohexyl-4-(hydroxymethyl)-3-[4-(4-methoxyphenyl)phenyl]azetidine-1-carboxamide
N-(cyclohexylmethyl)-2-[(2R,3S,6S)-3-[(3-fluorophenyl)carbamoylamino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
N-(cyclohexylmethyl)-2-[(2S,3S,6R)-3-[[(3-fluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
N-(cyclohexylmethyl)-2-[(2S,3S,6S)-3-[[(3-fluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]oxan-3-yl]-1,3-benzodioxole-5-carboxamide
N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]-1,3-benzodioxole-5-carboxamide
(2S,3R,4R)-2-cyano-N-cyclohexyl-4-(hydroxymethyl)-3-[4-(4-methoxyphenyl)phenyl]-1-azetidinecarboxamide
(2S,3S,3aR,9bR)-7-(1-cyclopentenyl)-3-(hydroxymethyl)-6-oxo-N-[(1R)-1-phenylethyl]-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizine-2-carboxamide
(2S,3S,3aR,9bR)-3-(hydroxymethyl)-7-[(E)-2-phenylethenyl]-2-(piperidine-1-carbonyl)-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizin-6-one
N-(cyclohexylmethyl)-2-[(2R,3R,6S)-3-[[(3-fluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
N-(cyclohexylmethyl)-2-[(2R,3R,6R)-3-[[(3-fluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]oxan-3-yl]-1,3-benzodioxole-5-carboxamide
N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]oxan-3-yl]-1,3-benzodioxole-5-carboxamide
(2S,3S,4S)-2-cyano-N-cyclohexyl-4-(hydroxymethyl)-3-[4-(4-methoxyphenyl)phenyl]-1-azetidinecarboxamide
(2R,3R,3aS,9bS)-7-(1-cyclopentenyl)-3-(hydroxymethyl)-6-oxo-N-[(1R)-1-phenylethyl]-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizine-2-carboxamide
(2R,3R,3aS,9bS)-7-(1-cyclopentenyl)-3-(hydroxymethyl)-6-oxo-N-[(1S)-1-phenylethyl]-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizine-2-carboxamide
(2S,3S,3aR,9bR)-7-(cyclopenten-1-yl)-3-(hydroxymethyl)-6-oxo-N-[(1S)-1-phenylethyl]-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizine-2-carboxamide
(1R,9S,10S,11S)-12-(cyclopropylmethyl)-11-(3,4-dihydro-1H-isoquinoline-2-carbonyl)-10-(hydroxymethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one
N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]-1,3-benzodioxole-5-carboxamide
(2R,3S,4R)-2-cyano-N-cyclohexyl-4-(hydroxymethyl)-3-[4-(4-methoxyphenyl)phenyl]-1-azetidinecarboxamide
1-[(1R,2aR,8bR)-4-[cyclohexyl(oxo)methyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-2-(2-pyridinyl)ethanone
(1S,9R,10R,11R)-12-(cyclopropylmethyl)-11-(3,4-dihydro-1H-isoquinoline-2-carbonyl)-10-(hydroxymethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one
[(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]-phenylmethanone
(6S,7R,8R)-8-(hydroxymethyl)-2-oxo-7-[4-[(E)-2-phenylethenyl]phenyl]-N-propan-2-yl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6R,7S,8S)-8-(hydroxymethyl)-2-oxo-7-[4-[(E)-2-phenylethenyl]phenyl]-N-propan-2-yl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
cyclohexyl-[(2R,3S)-2-(hydroxymethyl)-1-[oxo(3-pyridinyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]methanone
cyclohexyl-[(2S,3S)-2-(hydroxymethyl)-1-[oxo(3-pyridinyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]methanone
N-(cyclohexylmethyl)-2-[(2S,3R,6S)-3-[[(3-fluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
N-(cyclohexylmethyl)-2-[(2R,3S,6R)-3-[[(3-fluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
(2R,3R,4R)-2-cyano-N-cyclohexyl-4-(hydroxymethyl)-3-[4-(4-methoxyphenyl)phenyl]-1-azetidinecarboxamide
1-[(1R,2aS,8bS)-4-[cyclohexyl(oxo)methyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-2-(2-pyridinyl)ethanone
1-[(1S,2aS,8bS)-4-[cyclohexyl(oxo)methyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-2-(2-pyridinyl)ethanone
1-[(1S)-1-(hydroxymethyl)-7-methoxy-1,9-dimethyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]-2-phenylethanone
1-[(1R)-1-(hydroxymethyl)-7-methoxy-1,9-dimethyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]-2-phenylethanone
[(1R)-1-(hydroxymethyl)-7-methoxy-1-methyl-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]-phenylmethanone
[(1S)-1-(hydroxymethyl)-7-methoxy-1-methyl-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]-phenylmethanone
(6S,7S,8S)-8-(hydroxymethyl)-2-oxo-7-[4-[(E)-2-phenylethenyl]phenyl]-N-propan-2-yl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6S,7S,8R)-8-(hydroxymethyl)-2-oxo-7-[4-[(E)-2-phenylethenyl]phenyl]-N-propan-2-yl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6R,7R,8R)-8-(hydroxymethyl)-2-oxo-7-[4-[(E)-2-phenylethenyl]phenyl]-N-propan-2-yl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6R,7R,8S)-8-(hydroxymethyl)-2-oxo-7-[4-[(E)-2-phenylethenyl]phenyl]-N-propan-2-yl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
cyclohexyl-[(2R,3R)-2-(hydroxymethyl)-1-[oxo(3-pyridinyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]methanone
cyclohexyl-[(2S,3R)-2-(hydroxymethyl)-1-[oxo(3-pyridinyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]methanone
N-[(E)-(4-hydroxy-3-methoxyphenyl)methylideneamino]-2-oxo-3-spiro[4H-isoquinoline-3,1-cyclopentane]-1-ylpropanamide
sodium;[(3S,8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate
ACT-333679
A member of the class of pyrazines that is {4-[(propan-2-yl)(pyrazin-2-yl)amino]butoxy}acetic acid carrying two additional phenyl substituents at positions 5 and 6 on the pyrazine ring. The active metabolite of selexipag, an orphan drug used for the treatment of pulmonary arterial hypertension.
5-(4,5-dimethoxy-7-methylnaphthalen-1-yl)-6,8-dimethoxy-1,3-dimethyl-3,4-dihydroisoquinoline
5-hydroxy-4-(1-hydroxy-6-{5-hydroxy-1,2,7-trimethyl-3,9,10-trioxatricyclo[4.3.1.0²,⁴]decan-8-yl}-4-methylhepta-2,4-dien-1-ylidene)-2h-pyrrol-3-one
5-(4,5-dimethoxy-2-methylnaphthalen-1-yl)-8-methoxy-1,2,3-trimethyl-3,4-dihydroisoquinolin-6-one
(1r,3r,4s,7s,8s,11s)-3-ethyl-7-methyl-11-[(2s,4s)-4-methyl-5-oxooxolan-2-yl]-2,5-dioxa-12-azatetracyclo[10.4.1.0¹,³.0⁴,⁸]heptadecane-6,9,17-trione
(2e)-n-[2-(4-{[(2e)-3,7-dimethylocta-2,6-dien-1-yl]oxy}phenyl)ethyl]-3-methanesulfonyl-n-methylprop-2-enamide
7- O- methylhayatidine
{"Ingredient_id": "HBIN013409","Ingredient_name": "7- O- methylhayatidine","Alias": "NA","Ingredient_formula": "C26H29NO4","Ingredient_Smile": "CC1CC2=C(C(=CC(=C2C(=N1)C)OC)OC)C3=C4C=CC=C(C4=C(C=C3C)OC)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "37328","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
ancistrocladisine
{"Ingredient_id": "HBIN015991","Ingredient_name": "ancistrocladisine","Alias": "NA","Ingredient_formula": "C26H29NO4","Ingredient_Smile": "CC1CC2=CC(=C(C(=C2C(=N1)C)OC)C3=C4C=CC=C(C4=C(C=C3C)OC)OC)OC","Ingredient_weight": "419.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1143","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "14287488","DrugBank_id": "NA"}